| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/06/2002 | CA2439477A1 Circular probe amplification (cpa) using energy-transfer primers |
| 09/06/2002 | CA2439472A1 Methods and compositions for modifying apolipoprotein b mrna editing |
| 09/06/2002 | CA2439400A1 Non-oligomerizing tandem fluorescent proteins |
| 09/06/2002 | CA2439383A1 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/06/2002 | CA2439335A1 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas |
| 09/06/2002 | CA2439332A1 Diagnostic test for the detection of chromosomal abnormalities in a fetus |
| 09/06/2002 | CA2439303A1 Methods for identifying peptides which modulate a biological process |
| 09/06/2002 | CA2439294A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 09/06/2002 | CA2439283A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 09/06/2002 | CA2439279A1 Chemokine receptors and disease |
| 09/06/2002 | CA2439190A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 09/06/2002 | CA2439185A1 Vector constructs |
| 09/06/2002 | CA2439168A1 Modified thrombopoietin with reduced immunogenicity |
| 09/06/2002 | CA2439155A1 Isolated human tumor supressor proteins, nucleic acid molecules encoding these human tumor supressor proteins, and uses thereof |
| 09/06/2002 | CA2439150A1 Avilamycin derivatives |
| 09/06/2002 | CA2439115A1 Novel oncolytic adenoviral vectors |
| 09/06/2002 | CA2438934A1 Chondrogenic potential of human bone marrow-derived cd105+ cells by bmp |
| 09/06/2002 | CA2438923A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2438901A1 Proteins in a porous support |
| 09/06/2002 | CA2438899A1 Method for determining efficacy of reverse cholesterol transport enhancing agents |
| 09/06/2002 | CA2438886A1 Fusion protein for the secretion of a protein of interest into the supernatant of the bacterial culture |
| 09/06/2002 | CA2438884A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2438832A1 Transgenic knockouts of bace-1 |
| 09/06/2002 | CA2438798A1 Biosynthesis of polyketide synthase substrates |
| 09/06/2002 | CA2438710A1 <i>nomuraeae rileyi</i>-origin ecdysteroid 22-oxidase and molt hormone inactivation system with the use of the same |
| 09/06/2002 | CA2438696A1 Polynucleotide formulation for enhanced intracellular transfer |
| 09/06/2002 | CA2438680A1 Genes encoding proteolytic enzymes from aspargilli |
| 09/06/2002 | CA2438652A1 Method for identification of t-cell epitopes and use for preparing molecules with reeduced immunogenicity |
| 09/06/2002 | CA2438617A1 Cloning of transgenic animals comprising artificial chromosomes |
| 09/06/2002 | CA2438612A1 Primordial germ cell-based germ line production of birds |
| 09/06/2002 | CA2438406A1 Materials and methods for the induction of premature chromosome condensation |
| 09/06/2002 | CA2438388A1 Manipulation of sucrose synthase genes to improve stalk and grain quality |
| 09/06/2002 | CA2438273A1 Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 09/06/2002 | CA2438212A1 Biosensor for detecting chemical agents |
| 09/06/2002 | CA2438205A1 Enzymes having alpha amylase activity and methods of use thereof |
| 09/06/2002 | CA2437898A1 Interferon-alpha induced gene |
| 09/06/2002 | CA2437516A1 Heterocarpine, a human ghrh-binding protein |
| 09/06/2002 | CA2437364A1 Proteins and nucleic acids encoding same |
| 09/06/2002 | CA2437313A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/06/2002 | CA2437218A1 Modified and stabilized gdf propeptides and uses thereof |
| 09/06/2002 | CA2435747A1 Bfit (brown fat inducible thioesterase) polypeptides and polynucleotides and their use |
| 09/06/2002 | CA2434690A1 Proteins, polynucleotides encoding them and methods of using the same |
| 09/06/2002 | CA2432029A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/06/2002 | CA2430702A1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 09/06/2002 | CA2430192A1 Enzymes having dehalogenase activity and methods of use thereof |
| 09/06/2002 | CA2429501A1 Recombinant viral switches for the control of gene expression in plants |
| 09/06/2002 | CA2429347A1 Manipulation of the phenolic acid content and digestibility of plant cell walls by targeted expression of genes encoding cell wall degrading enzymes |
| 09/06/2002 | CA2362784A1 Methods for producing protein domains and analyzing three dimensional structures of proteins by using said domains |
| 09/05/2002 | US20020124286 Plants resistant to WT strains of cucumber mosaic virus |
| 09/05/2002 | US20020124285 Plant regulatory sequences for selective control of gene expression |
| 09/05/2002 | US20020124284 Nucleotide sequences coding root regulatory polypeptide for use in soil remediation and prevention of soil erosion |
| 09/05/2002 | US20020124282 Plant reproduction polynucleotides and methods of use |
| 09/05/2002 | US20020124281 Genetically engineering plant; obtain cells, transform with expression vector containing preferential polypetide, express vector, monitor phenotypic expression of plants |
| 09/05/2002 | US20020124280 Generation of a genetically engineered plant; obtain plant, incubate with nucleotide sequences, transform cells, monitor phenotype of plant |
| 09/05/2002 | US20020124279 Mre11 orthologue and uses thereof |
| 09/05/2002 | US20020124278 Generating genetically engineered plant for the generation of exogenous proteins; obtain seed, incubate with nucleotide sequences, monitor seeds for expression of nucleotide sequences, propagate seeds |
| 09/05/2002 | US20020124277 Unactivated oocytes as cytoplast recipients for nuclear transfer |
| 09/05/2002 | US20020124276 Nucleotide sequences coding enzymatic polypeptide for use in metaboism of vitamin b6 in seeds |
| 09/05/2002 | US20020124274 Delivery system |
| 09/05/2002 | US20020124272 Diploid animal cell for use in the treatment of drug addiction, epilepsey, withdrawal syndrome and muscle spasm |
| 09/05/2002 | US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound |
| 09/05/2002 | US20020123623 Nucleotide sequences coding transcription factor for use in the generation of disease resistant and pest resistant plants |
| 09/05/2002 | US20020123622 Novel human kinases and polynucleotides encoding the same |
| 09/05/2002 | US20020123621 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of brain, psychological, and immumological disorders |
| 09/05/2002 | US20020123618 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune, thyroid and grave's disease |
| 09/05/2002 | US20020123616 Prostate specific antigen (PSA) -proteinase inhibitors complexes |
| 09/05/2002 | US20020123614 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 09/05/2002 | US20020123611 Membrane polypeptides for use in treatment of kidney defects |
| 09/05/2002 | US20020123481 C-fos induced growth factor (FIGF) and DNA encoding same |
| 09/05/2002 | US20020123479 Immunostimulation mediated by gene-modified dendritic cells |
| 09/05/2002 | US20020123477 Contacting a target cell with DNA-damaging agent; removing DNA-damaging agent from target cell; transferring transgene into target cell between about 1-3 days after removing DNA-damaging agent |
| 09/05/2002 | US20020123475 32626, a novel human UDP-glycosyltransferase and uses thereof |
| 09/05/2002 | US20020123474 Human GTP-Rho binding protein2 |
| 09/05/2002 | US20020123473 For therapy of asthma |
| 09/05/2002 | US20020123471 Useful as a gene transfer vehicle for gene therapy, i.e. of the central nervous system |
| 09/05/2002 | US20020123464 Used for assessing whether test compound is useful for modulating phenomenon selected from group consisting of cell signaling, cell growth, cell differentiation, tumorigenesis, tumor growth, tumor metastasis, cell motility, etc. |
| 09/05/2002 | US20020123463 As diagnostics, biosensors and bioreactors, pharmaceuticals |
| 09/05/2002 | US20020123462 Modified ciliary neurotrophic factor, method of making and methods of use thereof |
| 09/05/2002 | US20020123458 Endostatin protein and fragments thereof |
| 09/05/2002 | US20020123454 Assaying ability of compound to modulate a NT69 nucleic acid expression or NT69 polypeptide activity, thereby identifying a compound capable of treating a pain disorder |
| 09/05/2002 | US20020123427 Plant phosphomevalonate kinases |
| 09/05/2002 | US20020123155 Biochemical sensor and biochemical testing system using the same |
| 09/05/2002 | US20020123149 Methods for generating hypermutable yeast |
| 09/05/2002 | US20020123148 Targeting preferential gene expression in somatic cell tissue; obtain cells, transform with nucleotide sequences, monitor cells for adjustment in gene exprssion patterns, recover cells with adjument in gene expression patterns |
| 09/05/2002 | US20020123147 Gene transfer with adenoviruses having modified fiber proteins |
| 09/05/2002 | US20020123146 Cell culture; for use as tool in gene therapy and cel packaging |
| 09/05/2002 | US20020123145 Methods for the replacement, translocation and stacking of DNA in eukaryotic genomes |
| 09/05/2002 | US20020123143 Cellular composition for use in the treatment and repair of bone and nervous system disorders |
| 09/05/2002 | US20020123141 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 09/05/2002 | US20020123139 Antibodies which bind specifically to activin receptor like kinases |
| 09/05/2002 | US20020123138 Human VNO receptor (R1) |
| 09/05/2002 | US20020123124 Mutant amylase for use in detergents and prepartion of textiles |
| 09/05/2002 | US20020123123 Cutinase variants |
| 09/05/2002 | US20020123122 Human DNase |
| 09/05/2002 | US20020123120 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 09/05/2002 | US20020123119 Nucleotide sequences coding enzymatic polypeptide for use in screening bactericides and for treatment and prevention of infections |
| 09/05/2002 | US20020123114 Polypeptide for use in the diagnosis of cancer of the nervous system |
| 09/05/2002 | US20020123113 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 09/05/2002 | US20020123109 Biotin biosynthetic genes |
| 09/05/2002 | US20020123108 Fusion proteins between antigenic amino acid sequences and beta-2- microglobulin |